Safety profile of 0.0015% tafluprost eye drops in China: a post-marketing observational study.
Chen XL, Fu YJ, Qu B, Wang YW, Tang X, Wang YH, Zhou GY, Lin MK, Shen JY, Yao J, Li SY, Wu MQ, Peng HZ, Lai MY, Wu RY, Zhang YN, Li Y, Wu XJ, Zhang MC, Guo SP, Sun XH.
Chen XL, et al. Among authors: li y, li sy.
Int J Ophthalmol. 2023 Jan 18;16(1):108-114. doi: 10.18240/ijo.2023.01.16. eCollection 2023.
Int J Ophthalmol. 2023.
PMID: 36659941
Free PMC article.